Novel agents in the treatment of lung cancer: Conference summary statement

被引：22

作者：

Lynch, TJ

Adjei, AA

Bunn, PA

DuBois, RN

Gandara, DR

Giaccone, G

Govindan, R

Herbst, RS

Johnson, BE

Khuri, FR

Perez-Soler, R

Rosell, R

Rowinsky, EK

Sandler, AB

Scagliotti, GV

Schiller, JH

Shapiro, GI

Socinski, MA

Hart, CS

机构：

[1] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA

[2] Mayo Clin, Rochester, MN USA

[3] Univ Colorado, Ctr Canc, Denver, CO 80262 USA

[4] Vanderbilt Univ, Med Ctr, Div Gastroenterol, Nashville, TN USA

[5] Univ Calif Sacramento, Davis Canc Ctr, Sacramento, CA USA

[6] Vrije Univ Amsterdam, Ctr Med, Dept Med Oncol, Amsterdam, Netherlands

[7] Washington Univ, Sch Med, Div Oncol, St Louis, MO USA

[8] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA

[9] Lowe Ctr Thorac Oncol, Dana Farber Canc Inst, Boston, MA USA

[10] Emory Univ, Winship Canc Ctr, Atlanta, GA 30322 USA

[11] Montefiore Med Ctr, Bronx, NY 10467 USA

[12] Hosp Germans Trias & Pujol, Inst Catala Oncol, Barcelona, Spain

[13] Canc Therapy & Res Ctr S Texas, Int Drug Dev, San Antonio, TX 78229 USA

[14] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[15] Univ Turin, Dept Clin & Biol Sci, S Luigi Gonzaga Hosp, Turin, Italy

[16] Univ Wisconsin, Sch Med, Madison, WI USA

[17] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[18] Univ N Carolina, Div Hematol Oncol, Chapel Hill, NC USA

[19] InforMED, Narberth, PA USA

来源：

CLINICAL CANCER RESEARCH | 2004年 / 10卷 / 12期

关键词：

D O I：

10.1158/1078-0432.CCR-040021

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

下载

页码：4199S / 4204S

页数：6

共 50 条

[1] Summary statement - Novel Agents in the Treatment of Lung Cancer: Fifth Cambridge Conference assessing opportunities for combination therapy
Lynch, Thomas J., Jr.
Blumenschein, George R., Jr.
Engelman, Jeffrey A.
Espinoza-Delgado, Igor
Govindan, Ramaswamy
Hanke, Jeff
Hanna, Nasser H.
Heymach, John V.
Hirsch, Fred R.
Janne, Pasi A.
Lilenbaum, Rogerio C.
Natale, Ronald B.
Riely, Gregory J.
Sequist, Lecia V.
Shapiro, Geoffrey T.
Shaw, Alice
Shepherd, Frances A.
Socinski, Mark
Sorensen, A. Gregory
Wakelee, Heather A.
Weitzman, Aaron
JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (06) : S107 - S112
[2] Summary statement:: Novel agents in the treatment of lung cancer:: Advances in epidermal growth factor receptor-targeted agents
Lynch, Thomas J.
Adjei, Alex A.
Bunn, Paul A., Jr.
Eisen, Tim G.
Engelman, Jeffrey
Goss, Glenwood D.
Haber, Daniel A.
Heymach, John V.
Jaenne, Pasi A.
Johnson, Bruce E.
Johnson, David H.
Lilenbaum, Rogerio C.
Meyerson, Matthew
Sandler, Alan B.
Sequist, Lecia V.
Settleman, Jeffrey
Wong, Kwok-Kin
Hart, Carol S.
CLINICAL CANCER RESEARCH, 2006, 12 (14) : 4365S - 4371S
[3] Early stage lung cancer - New approaches to evaluation and treatment: Conference summary statement
Lynch, TJ
Bogart, JA
Curran, WJ
DeCamp, MM
Gandara, DR
Goss, G
Henschke, CI
Jett, JR
Johnson, BE
Kelly, KL
Le Chevalier, T
Mulshine, JL
Scagliotti, GV
Schiller, JH
Shaw, A
Thatcher, N
Vokes, EE
Wood, DE
Hart, C
CLINICAL CANCER RESEARCH, 2005, 11 (13) : 4981S - 4983S
[4] Novel agents in the treatment of lung cancer: Fourth Cambridge conference
Lynch, Thomas J.
Bonomi, Philip D.
Butts, Charles
Davies, Angela M.
Engelman, Jeffrey
Govindan, Ramaswamy
Herbst, Roy S.
Heymach, John V.
Johnson, Bruce E.
Martins, Renato G.
Perez-Soler, Roman
Riely, Gregory J.
Sandler, Alan B.
Sequist, Lecia V.
Socinski, Mark A.
Wong, Kwok-Kin
Hart, Carol S.
CLINICAL CANCER RESEARCH, 2007, 13 (15) : 4583S - 4588S
[5] Novel targeted agents in the treatment of lung cancer
Saba, N
Khuri, F
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (06) : 609 - 629
[6] Summary of the Japanese Respiratory Society statement for the treatment of lung cancer with comorbid interstitial pneumonia
Ogura, Takashi
Takigawa, Nagio
Tomii, Keisuke
Kishi, Kazuma
Inoue, Yoshikazu
Ichihara, Eiki
Homma, Sakae
Takahashi, Kazuhisa
Akamatsu, Hiroaki
Ikeda, Satoshi
Inase, Naohiko
Iwasawa, Tae
Ohe, Yuichiro
Ohta, Hiromitsu
Onishi, Hiroshi
Okamoto, Isamu
Ogawa, Kazumasa
Kasahara, Kazuo
Karata, Hiroki
Kishimoto, Takumi
Kitamura, Yuka
Gemma, Akihiko
Kenmotsu, Hirotsugu
Sakashita, Hiroyuki
Sakamoto, Susumu
Sekine, Katsutoshi
Takiguchi, Yuichi
Tada, Yuji
Toyooka, Shinichi
Nakayama, Yuko
Nishioka, Yasuhiko
Hagiwara, Koichi
Hanibuchi, Masaki
Fukuoka, Junya
Minegishi, Yuji
Yanagihara, Toyoshi
Yamamoto, Nobuyuki
Yamamoto, Hiromasa
Gaga, Mina
Fong, Kwun M.
Powell, Charles A.
Kiura, Katsuyuki
RESPIRATORY INVESTIGATION, 2019, 57 (06) : 512 - 533
[7] Novel targeted agents for the treatment of lung cancer in China
Liu, Si-Yang
Mok, Tony
Wu, Yi-Long
CANCER, 2015, 121 : 3089 - 3096
[8] Inhibitor treatment in haemophillas A and B: Summary statement for the 2006 International Consensus Conference
Berntorp, E.
Shapiro, A.
Astermark, J.
Blanchette, V. S.
Collins, P. W.
Dimichele, D.
Escuriola, C.
Hay, C. R. M.
Hoots, W. K.
Leissinger, C. A.
Negrier, C.
Oldenburg, J.
Peerlinck, K.
Reding, M. T.
Hart, C.
HAEMOPHILIA, 2006, 12 : 1 - 7
[9] Endocrine and Targeted Manipulation of Breast Cancer: Summary statement for the Sixth Cambridge Conference
Come, Steven E.
Buzdar, Aman U.
Ingle, James N.
Johnston, Stephen R. D.
Brodie, Angela M.
Coombes, R. Charles
Miller, William R.
Pritchard, Kathleen I.
Winer, Eric P.
Zujewski, Jo Anne
Goss, Paul E.
CANCER, 2008, 112 (03) : 673 - 678
[10] Advances in treating metastatic bone cancer: Summary statement for the First Cambridge Conference
Lipton, Allan
Berenson, James R.
Body, Jean-Jacques
Boyce, Brendan F.
Bruland, Oyvind S.
Carducci, Michael A.
Cleeland, Charles S.
Clohisy, Denis R.
Coleman, Robert E.
Cook, Richard J.
Guise, Theresa A.
Pearse, Roger N.
Powles, Trevor J.
Rogers, Michael J.
Roodman, G. David
Smith, Matthew R.
Suva, Larry J.
Vessella, Robert L.
Weilbaecher, Katherine N.
King, Laura
CLINICAL CANCER RESEARCH, 2006, 12 (20) : 6209S - 6212S

← 1 2 3 4 5 →